THNR vs. CNCR ETF Comparison

Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to Loncar Cancer Immunotherapy ETF (CNCR)
THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description

The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$23.36

Average Daily Volume

2,542

Number of Holdings *

15

* may have additional holdings in another (foreign) market
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$13.56

Average Daily Volume

3,680

Number of Holdings *

67

* may have additional holdings in another (foreign) market
Performance
Period THNR CNCR
30 Days -10.14% -8.93%
60 Days -13.84% -10.14%
90 Days -16.31% -9.48%
12 Months 29.20%
1 Overlapping Holdings
Symbol Grade Weight in THNR Weight in CNCR Overlap
MRK F 5.07% 1.24% 1.24%
THNR Overweight 14 Positions Relative to CNCR
Symbol Grade Weight
LLY F 14.11%
NVO D 13.26%
PFE D 5.16%
AMGN D 5.11%
TMO F 4.94%
AZN D 4.86%
WST C 4.55%
TEVA D 3.84%
VKTX F 2.26%
CTLT B 2.14%
HIMS B 0.71%
OPK C 0.24%
ALT C 0.22%
TERN F 0.12%
THNR Underweight 66 Positions Relative to CNCR
Symbol Grade Weight
GLUE C -2.03%
EXEL B -1.9%
RVMD C -1.84%
ACLX C -1.73%
BMY B -1.72%
ELVN D -1.68%
XNCR B -1.66%
MRSN D -1.62%
BPMC C -1.58%
KPTI C -1.57%
REPL B -1.56%
GNLX F -1.56%
MGNX F -1.55%
HCM D -1.54%
SWTX C -1.47%
CRBU F -1.47%
JANX C -1.46%
ERAS C -1.46%
DAWN F -1.44%
IMCR D -1.42%
RXRX F -1.39%
SDGR C -1.39%
ARVN D -1.39%
AURA D -1.38%
LYEL F -1.35%
SNDX F -1.34%
MRUS F -1.33%
KYMR D -1.32%
RPTX F -1.32%
GERN D -1.31%
IOVA F -1.3%
RCUS F -1.29%
NRIX D -1.29%
FHTX D -1.26%
NUVB C -1.26%
BNTX D -1.25%
ZNTL F -1.25%
BCYC F -1.24%
YMAB F -1.24%
BMEA F -1.22%
PGEN F -1.2%
CGEM F -1.2%
ALLO F -1.18%
NUVL D -1.18%
VOR D -1.17%
GMAB F -1.17%
TYRA F -1.16%
KURA F -1.16%
ACRV F -1.15%
AUTL F -1.13%
STRO F -1.12%
LEGN F -1.1%
IDYA F -1.07%
TSVT F -1.06%
REGN F -1.0%
ITOS F -0.98%
IPHA F -0.98%
SMMT D -0.97%
ACET F -0.97%
IMRX F -0.95%
IMTX F -0.93%
RLAY F -0.91%
IGMS F -0.88%
RAPT F -0.88%
FATE F -0.87%
PRLD F -0.55%
Compare ETFs